Tracking Spread of the Novel Coronavirus - COVID-19
China better at fighting Covid than the Rest of World
Studies show the first case of coronavirus symptoms in China was most likely recorded on Dec 1. While China has the vast majority of infections even today, the chart shows that growth of Covid-19 cases (the disease caused by the SARS-CoV-2 virus) have grown at a rate much faster than in China. Such a growth rate would suggest over a million cases in less than 30 days.
[as on 24th April, 2020 6:09 P.M.]
Coronavirus Explainer Video
Our full explainer video tells the story so far, gives a perspective on pandemics, explains the biology of how COVID-19 attacks the body, and gives you tips on how to protect yourself. Through 3D medical animation, understand the structure of the Coronavirus and how it hijacks cells into replicating the virus.
Want to get updates on novel coronavirus?
Tracking the spread of nCoV
We track the daily change in the number of confirmed cases, death toll and recoveries. We are also keeping abreast of the R0 (pronounce R-Naught) or average transmission rate.
Biology of nCoV
The structure of COVID-19 has been revealed. Using 3D medical animation we show the structure and explain the role of each component of the 2019 Novel Coronavirus.
Mechanism of Action
How does the virus transmit from human to human ? How does it gain entry into cells ? How does it replicate, destroy and go on to infect more cells ? These are paramount questions for treatment, because if you can stop the virus sequence anywhere, you can potentially stop the virus. Using medical animation we explore the emerging biology.
How To Protect Yourself?
The CDC, NIH, WHO and many independents have shared guidelines on how to best protect yourself. We’ve compiled the best recommendations into a simple, downloadable PDF. It’s free to download and share under the WIKI Creative Commons License.
Image Credits: BBC News
Image Credits: CBS News
Image Credits: Al-Jazeera
Search For Vaccine/Treatment
“Researchers have tested a potential vaccine for COVID-19 in mice, which when delivered through a fingertip-sized patch, produced an immune response specific to the novel coronavirus at quantities thought to be sufficient for neutralising the virus. The study, published in the journal EBioMedicine, noted that when tested in mice, the PittCoVacc — short for Pittsburgh Coronavirus Vaccine — generated a surge of antibodies against the coronavirus, SARS-CoV-2, within two weeks of delivering it. “We had previous experience on SARS-CoV in 2003 and MERS-CoV in 2014. These two viruses, which are closely related to SARS-CoV-2, teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus,” said co-senior author Andrea Gambotto from the University of Pittsburgh in the US.”See More
Frequently Asked Questions
Compiled from a number of sources.